(Q37418300)

20 August 2017

1 reference

title

Profiling CD antigens on leukaemias with an antibody microarray (English)

1 reference

20 August 2017

1 reference

1 reference

Nicole Barber

1

1 reference

20 August 2017

Swetlana Gez

2

1 reference

20 August 2017

Larissa Belov

3

1 reference

20 August 2017

Stephen P Mulligan

4

1 reference

20 August 2017

Adrian Woolfson

5

1 reference

20 August 2017

Richard I Christopherson

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

17 March 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

583

1 reference

20 August 2017

issue

11

1 reference

20 August 2017

page(s)

1785-1791

1 reference

Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Resolving and classifying haematopoietic bone-marrow cell populations by multi-dimensional analysis of flow-cytometry data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Immunophenotypic changes induced on human HL60 leukaemia cells by 1alpha,25-dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol-13-acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

CD4 function in thymocyte differentiation and T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

The structure and main functions of aminopeptidase N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Toll-like receptors in the induction of the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Interaction sites on human IgG-Fc for FcgammaR: current models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Polarization and directed migration of murine neutrophils is dependent on cell surface expression of CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

The biology of CD45 and its use as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Adhesion of neutrophils to fibronectin: role of the cd66 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Interleukin 6 and its receptor: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

Multiplex detection of surface molecules on colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.03.018

10.1016/J.FEBSLET.2009.03.018

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference